James R. Kasinger is CLO & Secretary at CRISPR Therapeutics AG (CRSP). They have made 13 open-market trades across 1 company since 2021, most recently 2026-10-14.
CIK 0001708172
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CRSP | 95,857 | $4.7M |
Shares reported on the most recent Form 4, priced at the 2026-10-15 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CRSP | SELL | 2026-10-14 | 2026-10-15 | $49.26 | $51K | — | — | — |
| CRSP | SELL · 10b5-1 | 2026-10-06 | 2026-10-08 | $60.04 | $119K | — | — | — |
| CRSP | SELL · 10b5-1 | 2026-09-22 | 2026-09-24 | $60.24 | $626K | -4.3% | — | — |
| CRSP | SELL | 2026-03-23 | 2026-03-24 | $46.78 | $149K | +4.0% | +16.8% | +15.0% |
| CRSP | SELL | 2026-03-16 | 2026-03-17 | $48.26 | $166K | -7.2% | +13.0% | +6.7% |
| CRSP | SELL | 2026-03-11 | 2026-03-12 | $52.80 | $148K | -6.6% | +10.3% | -0.5% |
| CRSP | SELL | 2026-02-19 | 2026-02-20 | $52.58 | $111K | +14.9% | -10.2% | -4.3% |
| CRSP | SELL | 2025-10-14 | 2025-10-15 | $66.60 | $143K | -6.1% | -25.0% | -19.7% |
| CRSP | SELL | 2025-03-21 | 2025-03-24 | $41.23 | $263K | -23.2% | -9.3% | +7.2% |
| CRSP | SELL | 2025-03-11 | 2025-03-12 | $42.67 | $169K | -1.3% | -9.0% | -0.6% |
| CRSP | SELL | 2025-02-18 | 2025-02-19 | $53.67 | $1.2M | -19.6% | -21.6% | -25.4% |
| CRSP | SELL | 2024-10-14 | 2024-10-15 | $46.28 | $101K | -2.0% | -3.0% | -19.6% |
| CRSP | SELL | 2024-03-11 | 2024-03-12 | $77.15 | $609K | -4.0% | -15.7% | -19.6% |
| CRSP | SELL | 2024-02-20 | 2024-02-21 | $79.67 | $305K | -0.3% | -12.7% | -33.2% |
| CRSP | SELL | 2021-01-19 | 2021-01-20 | $204.79 | $10.5M | -14.5% | -23.2% | -37.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.